Sun Pharmaceutical Industries has entered into an agreement to acquire 100% outstanding shares of Innovcare Lifesciences. The deal is worth around Rs 271.2 crore. This strategic investment is aimed at strengthening the product portfolio of the company. The transaction is expected to be completed on or before July 31, 2026.
Innovcare Lifesciences is a company based in Mumbai and engaged in the business of marketing, distribution and sale of pharmaceutical drugs, nutraceutical and cosmeceutical products.
Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1874.70 |
| Dr. Reddys Labs. | 1328.35 |
| Cipla | 1437.35 |
| Zydus Lifesciences | 1099.10 |
| Lupin | 2367.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: